TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 315 filers reported holding TANDEM DIABETES CARE INC in Q4 2020. The put-call ratio across all filers is 0.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,579,000 | -82.2% | 43,572 | -65.0% | 0.35% | -78.5% |
| Q1 2022 | $14,496,000 | +27.6% | 124,654 | +65.1% | 1.63% | -1.0% |
| Q4 2021 | $11,364,000 | +80.0% | 75,500 | +42.7% | 1.64% | +76.6% |
| Q3 2021 | $6,315,000 | +56.9% | 52,900 | +28.0% | 0.93% | +86.9% |
| Q2 2021 | $4,025,000 | -64.7% | 41,320 | -58.8% | 0.50% | -76.4% |
| Q3 2020 | $11,389,000 | +95.3% | 100,345 | +70.2% | 2.11% | +77.4% |
| Q2 2020 | $5,831,000 | +0.6% | 58,943 | -34.6% | 1.19% | -37.8% |
| Q1 2020 | $5,797,000 | +52.5% | 90,081 | +41.3% | 1.91% | +89.8% |
| Q4 2019 | $3,801,000 | -26.3% | 63,767 | -27.1% | 1.01% | -40.1% |
| Q3 2019 | $5,157,000 | -18.7% | 87,435 | -11.1% | 1.68% | -18.4% |
| Q2 2019 | $6,344,000 | +111.4% | 98,325 | +108.1% | 2.06% | +94.0% |
| Q1 2019 | $3,001,000 | +29.4% | 47,255 | -22.7% | 1.06% | +13.4% |
| Q4 2018 | $2,320,000 | +46.5% | 61,105 | +65.3% | 0.94% | +70.4% |
| Q3 2018 | $1,584,000 | – | 36,975 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |